Lowenstein Sandler represented Catalyst Investors as the lead investor in a $20 million Series B financing round in Tava Health, Inc., a provider of virtual mental health and telehealth services to therapists and employee assistance programs. Existing investors Peterson Partners, Toba Capital, and SpringTide, along with new investor Blue Heron Capital, also participated in the funding round.
Founded in 2019, Tava Health is a cutting-edge mental health platform revolutionizing access to quality care. Bridging the gap between providers and those seeking support, Tava Health prioritizes therapists, offering an integrated suite with an electronic medical record, telehealth, billing, and referral management. Committed to breaking down barriers, Tava Health partners with employers, making mental health checkups as routine as other healthcare practices.
Catalyst Investors is a growth equity firm based in New York. Over the past 20-plus years, Catalyst has invested in rapidly growing technology companies and has established a successful track record of partnering with entrepreneurs and helping companies scale. Recent investments and exits include Breezeway, BrightFarms, ChowNow, Clinicient, EDB, Fusion, LinkSquares, Pax8, Presence and Weave.
The Lowenstein team included Michael A. Brosse, David J. Yovanoff, Bonnie E. Schipper, James C. Shehan, Megan Monson, and Jessica I. Kriegsfeld.
About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on venture and investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.
